MIT professor slams Harvard’s stem cell bid
An MIT biotechnologist has pleaded with Harvard University not to pursue plans to do therapeutic cloning. Associate Professor James Sherley wrote in the Boston Globe that “adult stem cell research is predicted to beat the pants off human therapeutic cloning research when it come to yielding significant advances in cell medicine.” Given the unresolved debate over whether the research is ethical, he argues, “no reviewing body could, in good faith, approve it”. Prof Sherley also argued that the moral argument for therapeutic cloning was self-contradictory. At least reproductive cloning (which he staunchly opposes) creates life, while therapeutic cloning destroys it.
Latest posts by Mumbai (see all)
- Prescribe morning-after pills to young teenagers, say US pediatric group - November 30, 2012
- Bahrain sentences protest docs to prison - November 28, 2012
- Terry Pratchett assisted suicide documentary wins International Emmy - November 27, 2012
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...
